www.mayflowerbio.com
Sales & Support: 314-485-5210

*

MLN4924

Supplier:
Catalogue number:
10-1311-01
Size:
1 mg
Product is available in:
  • USA
  • Canada
$90.00 Shipping is calculated in checkout

Nedd8 activating enzyme inhibitor. Targets Cullin2, which interacts with SARS-CoV-2 Orf10. Gordon et al. bioRxiv, Mar 23 2020, https://doi.org/10.1101/2020.03.22.002386.

  • Datasheet:   view or download
  • Applications:In clinical trials for other indication(s)
Product Type:

Biochemicals & reagents

CAS Number:

905579-51-3

Range:

1) Soucy, et al. (2009), An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458 732 2) Milhollen, et al., (2010) MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-(kappa)B-dependent lymphoma. Blood. 116 1515 3) Zhou et al. (2019) Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma; Int. J. Cancer, 145 763 4) Zhou et al. (2019) Neddylation: a novel modulator of the tumor microenvironment; Mol. Cancer 18 77

Limit of Detection:

443.53

Storage Temperature:

-20°C (des.)

Additional Information:

MLN4924 is a potent and selective NEDD8-activating enzyme (NAE) inhibitor (1) which disrupts cullin-RING ligase-mediated protein turnover leading to apoptosis in human tumor cells and suppresses the growth of human tumor xenografts in mice (2). This compound upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma (3). It also modulates tumor microenvironment (4) and is cell permeable.